Efficacy and Safety of LFG316 in Transplant Associated Microangiopathy (TAM) Patients
Clinical trial NCT02763644 · TERMINATED
Trial details
- NCT number
- NCT02763644
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-22
- Primary completion
- 2017-02-10
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.